Early Seizures May Affect Brain Wiring In Newborns
This study looked at whether the brain’s white matter differs in term newborns with genetic epilepsy in the neonatal period.
This hub covers epilepsy genetics: how gene changes can contribute to seizures (often in children). We translate studies on testing, results like VUS, and what findings may change for care.
No. It’s common in pediatrics, but adults can benefit from genetic testing, too, especially with unclear diagnosis or family history.
Sometimes. For certain conditions, results can guide medication choice, diet therapies, or referral decisions.
It usually means “not enough evidence yet.” It shouldn’t be treated as a definite cause, but it can be reclassified over time.
Not necessarily. Testing can miss some variants, and new gene links are still being discovered.
This study looked at whether the brain’s white matter differs in term newborns with genetic epilepsy in the neonatal period.
This paper is a seminar-style review about epilepsy care in adults with intellectual developmental disorders (IDD).
This paper was a scoping review, which means the authors gathered and summarized published research rather than testing a treatment in one new group of patients.
Researchers developed and independently validated a computer model to estimate whether a person with epilepsy would respond to valproic acid (VPA), a common first-line antiseizure medicine.
Researchers followed 12 adults with Down syndrome who had progressive myoclonus epilepsy in the setting of Alzheimer’s disease.
This study looked at sleep problems in people with KCNB1-related disorders, a genetic condition that can involve epilepsy, developmental difficulties, or both.
This study looked at whole-exome sequencing in 1,109 children with epilepsy at a single medical center.
This study looked at whether people with active epilepsy or inactive epilepsy were meeting aerobic exercise guidelines, and whether neighborhood social cohesion was related to this association.
This study looked at how adults with non-convulsive status epilepticus (NCSE) were treated in a 6-year ambispective registry, and whether treatment patterns were associated with seizure control, death in the hospital, or worse function at discharge.